Platelet-Rich Plasma Injections in Regenerative Orthopedic Medicine | NYU Langone Health
Experts at NYU Langone’s Center for Regenerative Orthopedic Medicine offer platelet-rich plasma injections for musculoskeletal conditions.
PNOC022: A Combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas (DMGs) including Diffuse Intrinsic Pontine Gliomas (DIPGs) at Initial Diagnosis Post-Radiation Therapy and at Time of Progression
This research is for kids and young adults who have a specific kind of brain tumor called DMG (Diffuse Midline Gliomas). We're testing different treatments (ONC201 with other new medications) for patients at different stages of the disease, like those who were just diagnosed, those who had radiation but no progression, and those with progression. The treatments include a drug called ONC201 and other new medicines. Making sure the treatment has few side effects is a top priority, and we'll watch patients closely for side effects. Some patients will have their tumor tissue collected to see how well the drugs reach the tumor. After these checks, patients will move into different phases of the study, like a maintenance phase where they'll keep getting the same treatment they started with. The goal is to understand how well and safely these treatments work for DMG at different stages. In the first phase, we won't specifically test the combination of drugs, but we'll carefully monitor safety throughout the study.
PNOC029: Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults
This study is designed for patients who have craniopharyngioma (a rare brain tumor). The usual treatment for craniopharyngioma involves surgery and radiation, which helps reduce the tumor and its return. However, these treatments can cause problems like trouble seeing, hormone issues, and other health challenges. When the tumor comes back, it's hard to treat.We need better ways to help battle craniopharyngioma without tough surgeries and lots of radiation. New research shows that certain pathways in the tumor could be targets for treatment. We want to test a combination of two drugs, nivolumab (FDA approved) and DAY101 (treats brain tumors in kids called 'pediatric low-grade gliomas'), to see if they can help kids and teens with craniopharyngioma. This study will check if the treatment is safe and works well.
Poisoning in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone are experts in managing poisoning in children and determining the appropriate treatment.
Policies & Disclaimers | NYU Langone Health
NYU Langone Health’s policies and disclaimers address HIPAA privacy and security, and other compliance-related concerns.
Polycystic Ovary Syndrome | NYU Langone Health
NYU Langone specialists are experienced in diagnosing and managing polycystic ovary syndrome, or PCOS.
Polycystic Ovary Syndrome in Adolescents | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone offer expert diagnosis and treatment of polycystic ovary syndrome.
Ponseti Method for Clubfoot in Children | NYU Langone Health
Orthopedic doctors at Hassenfeld Children’s Hospital at NYU Langone use the Ponseti method to treat infants diagnosed with clubfoot.
Post-Cardiopulmonary Bypass Vasoplegia: Cytokine/Chemokine/Immunotranscriptomic Causes or Consequences
All patients undergoing open heart surgery with the utilization of cardiopulmonary bypass (CPB) are at risk for developing varying degrees of vasoplegia. Although a precise definition is lacking, vasoplegia is a physiologic state characterized by hypotension (systolic blood pressure
Post-COVID Care Program | NYU Langone Health
Experts at NYU Langone’s Post-COVID Care Program provide comprehensive care for people who are experiencing long-term effects of the disease.